39 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 39 of 39 clinical reviews.
A clinical and coverage guide to Anthem (Elevance Health) Prometrium benefits, prior authorization criteria, step therapy, formulary tier, appeals, and cost-reduction options for micronized progesterone.
A clinical and insurance guide to Prometrium (micronized progesterone) coverage under Blue Cross Blue Shield Federal Employee Program and affiliated BCBS commercial plans, including formulary tiers, prior authorization, step therapy, and appeal strategies.
A guide to Cigna coverage for Prometrium (micronized progesterone): formulary tier, prior-authorization criteria, step therapy, appeal steps, and cost-saving options.
Find out whether Humana covers Prometrium (micronized progesterone), what formulary tier it sits on, prior-authorization requirements, step-therapy rules, and how to appeal a denial.
A detailed guide to Kaiser Permanente's Prometrium formulary status, prior authorization criteria, step therapy requirements, appeals process, and cash-pay alternatives, prepared by the HealthRX.com Editorial Team.
A complete guide to TRICARE coverage for Prometrium (micronized progesterone), including formulary tier, prior authorization requirements, step therapy, appeals, and cost-saving strategies.
A clinical guide to UnitedHealthcare formulary placement, prior authorization criteria, step therapy requirements, and appeal strategies for Prometrium (micronized progesterone 100 mg / 200 mg).
Evidence-based guide to Prometrium dosing in adults aged 30, 49, covering standard regimens, clinical trial data from PEPI, bedtime administration, and practical considerations for premenopausal and perimenopausal women.
Evidence-based review of Prometrium (micronized progesterone) safety in geriatric patients 65+, covering fall risk, sedation, renal considerations, drug interactions, and deprescribing guidance.
Evidence-based safety profile of Prometrium (micronized progesterone) for young adults aged 18 to 29, covering side effects, fertility considerations, contraceptive status, and clinical monitoring.
A guide to micronized progesterone (Prometrium) safety for adults aged 30 to 49, covering clinical evidence, side effects, drug interactions, and dosing guidelines.
A breakdown of Prometrium (micronized progesterone) cost, mechanism, and clinical trade-offs versus MPA, norethindrone, levonorgestrel IUD, and compounded progesterone, with dosing tables, trial data, and real pricing.
Evidence-based guide to Prometrium (micronized progesterone) dosing in adults aged 50 to 64, covering standard regimens, safety adjustments, cardiovascular considerations, and bedtime administration.
A clinician-level review of Prometrium (micronized progesterone) dosing when liver function is compromised, covering mechanism, pharmacokinetics, FDA label guidance, and practical prescribing considerations.
Clinical guidance on micronized progesterone (Prometrium) dosing in patients with renal impairment, including pharmacokinetic data, FDA labeling gaps, and practical prescribing recommendations.
Evidence-based guide to Prometrium (micronized progesterone) drug-drug interactions, covering CYP3A4 metabolism, clinically significant co-medications, and prescribing considerations for HRT.
Micronized progesterone (Prometrium) is affected by food, grapefruit, St. John's Wort, and several other supplements through two distinct mechanisms: CYP3A4 metabolism and additive GABA-A sedation. Here is what is established, what is plausible but unproven, and how to think about timing your dose.
A clinical review of upcoming micronized progesterone formulations, pipeline candidates, and next-generation delivery systems beyond oral Prometrium capsules.
A complete clinical guide to Prometrium (micronized progesterone) dosing in adults aged 65 and older, covering standard doses, safety considerations, drug interactions, falls risk, and deprescribing criteria.
The full history of Prometrium (micronized progesterone), from early extraction failures to FDA approval, the PEPI trial, and its role in modern hormone replacement therapy.
A clinician-level review of micronized progesterone (Prometrium) safety in pregnancy and breastfeeding, covering FDA labeling, PubMed evidence, mechanism, dosing, and when to stop.
A clinical deep-dive into micronized progesterone (Prometrium) use in special populations including solid-organ transplant recipients, people living with HIV, patients with liver disease, older adults, and those with metabolic conditions. Covers mechanisms, drug interactions, and evidence-based dosing guidance.
A clinical review of Prometrium (micronized progesterone) manufacturing processes, supply chain events, FDA shortage records, and what prescribers and patients should know about availability.
A physician-level deep dive into how Prometrium (micronized progesterone) works, from progesterone receptor binding and genomic transcription to GABA-A modulation, endometrial protection, and lipid metabolism.
Forgot your Prometrium dose? Take it the same day you remember, or skip it if the next dose is within 8 hours. Don't double up; call if you miss 2 in a row.
Evidence-based monitoring guide for micronized progesterone (Prometrium) in adults aged 30 to 49, covering baseline labs, follow-up schedules, and safety checkpoints.
A clinical guide to monitoring micronized progesterone (Prometrium) in young adults aged 18 to 29, covering labs, cycle tracking, side-effect surveillance, and fertility planning considerations.
A monitoring schedule for Prometrium (micronized progesterone), covering baseline labs, follow-up bloodwork, endometrial surveillance, and long-term exam timelines.
A clinician-grade review of micronized progesterone (Prometrium) off-label applications, from preterm birth prevention to sleep support, ranked by strength of evidence.
A clinical review of Prometrium's patent history, generic micronized progesterone availability, FDA approvals, and what prescribers and patients should know about bioequivalence and switching.
A detailed clinical guide to the ADME profile of Prometrium (micronized progesterone), including absorption kinetics, first-pass metabolism, active metabolites like allopregnanolone, and renal elimination.
A physician-level review of real-world evidence for Prometrium (micronized progesterone), including registry data, observational cohorts, and how RWE compares to randomized trial findings for endometrial protection, breast safety, and cardiovascular outcomes.
A breakdown of Prometrium (micronized progesterone) regulatory status across the US, EU, Canada, and UK, including approval dates, authorized indications, formulation differences, and prescribing considerations.
A guide to micronized progesterone (Prometrium) safety for adults aged 50 to 64, covering cardiovascular risk, VTE data, cognitive effects, drug interactions, and dosing considerations.
A clinical review of Prometrium (micronized progesterone) safety signals, FDA black box warnings, post-marketing data, and how its risk profile compares to synthetic progestins.
Evidence-based guide to storing micronized progesterone (Prometrium) correctly, including temperature limits, light sensitivity, shelf life data, and what happens when capsules are exposed to heat or humidity.
A clinician-level guide to switching Prometrium (micronized progesterone) to or from other progestogens in hormone therapy, with trial data, mechanism of action, and step-by-step protocols.
Evidence-based guide to Prometrium (micronized progesterone) dosing for young adults aged 18, 29, covering indications, dose selection, timing, and clinical considerations.
Compare planned Prometrium off-days with stopping treatment, using actual regimens, hormone-therapy trials and the continuing-estrogen question.